Pharm
Levofloxacin
search
Levofloxacin
, Levaquin
See Also
Moxifloxacin
Third Generation Fluoroquinolone
Fluoroquinolone
Indications
Conditions
Community Acquired Pneumonia
Refractory acute
Bacteria
l
Sinusitis
(third line agent)
Activity Spectrum
Moderate to good
Gram Positive
activity (includes
Streptococcus Pneumoniae
)
Aerobic Gram Negative Rod
coverage (see other
Fluoroquinolone
s)
Enterobacteriaceae
Includes
Pseudomonas
coverage (similar to
Ciprofloxacin
)
Atypical
Bacteria
(similar to other
Fluoroquinolone
s)
Legionella pneumophila
Chlamydophila pneumoniae
Mycoplasma pneumoniae
Contraindications
See
Fluoroquinolone
Myasthenia Gravis
(exacerbates motor weakness)
Children
Relative contraindication due to risk of
Arthropathy
in animals
Studies have not demonstrated
Arthropathy
(other than transient large joint
Arthralgia
s)
Mechanism
See
Fluoroquinolone
Medications
Tablets: 250, 500 and 750 mg
Oral Solution: 25 mg/ml
Dosing
Adult
See
Anthrax
Community Acquired Pneumonia
Take 750 mg orally or IV daily for 5 days OR
Take 500 mg orally or IV daily for 7 to 14 days
Nosocomial Pneumonia
Take 750 mg orally or IV daily for 7 to 14 days
Pyelonephritis
(or other complicated
Urinary Tract Infection
)
Take 750 mg orally or IV daily for 5 days OR
Take 250 mg orally or IV daily for 10 days
Chronic Bacterial Prostatitis
Take 500 mg orally or IV daily for up to 28 days
Plague
Take 500 mg orally or IV daily for 10 to 14 days
Travelers Diarrhea
(not FDA approved)
Take 500 mg orally or IV daily for 1 to 3 days
Legionnaires Disease
Start: 1000 mg orally or IV on day 1
Next: 500 mg orally or IV daily
Renal Dosing
eGFR 20 to 49 ml/min
Dose 750 mg: Give 750 mg orally or IV every 48 hours
Dose 500 mg: Give 500 mg orally or IV once for loading dose, then 250 mg every 24 hours
eGFR 10 to 19 ml/min (or
Hemodialysis
)
Dose 750 mg: Give 750 mg orally or IV once for loading dose, then 500 mg every 48 hours
Dose 500 mg: Give 500 mg orally or IV once for loading dose, then 250 mg every 48 hours
Dose 250 mg: Give 250 mg orally or IV every 48 hours
Dosing
Child
See
Anthrax
See
Plague
See Precautions above under contraindications
Community Acquired Pneumonia
(not FDA Approved)
Age 6 months to 5 years
Give 8 to 10 mg/kg orally or IV twice daily
Age 5 to 16 years
Give 8 to 10 mg/kg (maximum 750 mg/day) orally or IV once daily
Adverse Effects
See
Fluoroquinolone
Fluoroquinolone
s have several serious warnings (e.g. tendon rupture,
Neuropathy
,
Aortic Dissection
)
QT Prolongation
with Levofloxacin (Levaquin)
Avoid in known
Prolonged QT
,
Hypokalemia
or in combination of Class 1 or
Class 3 Antiarrhythmic
s
Three fold increased risk of
Sudden Cardiac Death
while on Levofloxacin
This appears to be a class effect with most
Fluoroquinolone
s except
Ciprofloxacin
Ray (2013) N Engl J Med 366(20): 1881-90 [PubMed]
Neurologic Effects
Seizure
risk (all
Quinolone
s inhibit
GABA
)
CNS stimulation
Suicidality
Safety
Avoided in pregnancy (despite pregnancy Category C)
Cartilage damage risk
Unknown Safety in
Lactation
However, risk of pediatric
Arthropathy
Pharmacokinetics
Excellent oral
Bioavailability
Oral and Intravenous dosing are the same
Drug Interactions
Sulfonylurea
s and other antidiabetic medications
Hypoglycemia
risk
Warfarin
May potentiate
Anticoagulant
effects
Class 1 or
Class 3 Antiarrhythmic
s
See
Prolonged QT Interval due to Medication
QT Prolongation
risk when combined with Levofloxacin
Urine Drug Screen
False Positive
Opiate
urine screen
Drugs that interfere with absorption (give at least 2 hours before or after dose)
Antacid
s containing
Calcium
, aluminum or
Magnesium
Sucralfate
Iron
Zinc
Yogurt, milk or
Calcium
fortified juice (but may take with dairy containing meals)
Resources
Levofloxacin Tablet (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4181a7ac-2e84-68d4-e054-00144ff88e88
Levofloxacin Injection Solution (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=70c87464-1806-480a-8ebd-3f02987ff436
References
(2019) Comparison Table: Some Systemic
Fluoroquinolone
s, Med Lett Drugs Ther, p. e57
King (2000) Am Fam Physician 61(9):2741-8 [PubMed]
O'Donnell (2000) Infect Dis Clin North Am 14(2):489-513 [PubMed]
Oliphant (2002) Am Fam Physician 65(3):455-64 [PubMed]
Owens (2000) Med Clin North Am 84(6):1447-69 [PubMed]
Type your search phrase here